Molecular Profiling As a Necessity for Uncommon Ovarian Cancers

November 5, 2015 11:00 am

By: Laura Shawver

In 1998, Herceptin was approved for women with breast cancer whose tumors have extra copies of the Her2/ERBB2 gene and since that time, there have been more than 25 drugs approved to treat cancers with specific genetic … Read more